NFKB1 and alkaline phosphatase measurement: Administration of Rg100204, an aquaporin-9 (AQP9) inhibitor, reduced pancreatic and lung damage in animals with AP by interacting with the NF-κB and Nrf2 pathways and thus suppressing NLRP3 activation [99].